
Episode 077: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - part 1
The Fellow on Call: The Heme/Onc Podcast
00:00
Management of Relapsed DLBCL in Elderly Patients
This chapter explores treatment options for a 76-year-old woman with relapsed diffuse large B-cell lymphoma who cannot undergo CAR T-cell therapy or autologous transplant. It highlights the efficacy of polituzumab-vidotin combined with bendamustine and rituximab compared to traditional regimens, while addressing methodological concerns from clinical trials.
Transcript
Play full episode